Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen V Frye

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
SLAS Discovery : Advancing Life Sciences R & D|October 22, 2022
Discovery of hit compounds for methyl-lysine reader proteins from a target class DNA-encoded libraryDevan J Shell, Justin M Rectenwald, Peter H Buttery, et al.
Journal of Medicinal Chemistry|November 8, 2013
Pseudo-cyclization through intramolecular hydrogen bond enables discovery of pyridine substituted pyrimidines as new Mer kinase inhibitorsWeihe Zhang, Dehui Zhang, Michael A Stashko, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacyJohn A Allen, Julianne M Yost, Vincent Setola, et al.
Biochemistry|November 29, 2018
Correction to "Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID subunit 1"Junghyun L Suh, Brian Watts, Jacob I Stuckey, et al.
Biochemistry|March 21, 2018
Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1Junghyun L Suh, Brian Watts, Jacob I Stuckey, et al.
Science Signaling|July 18, 2019
Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancerDevon R Blake, Angelina V Vaseva, Richard G Hodge, et al.
European Journal of Medicinal Chemistry|September 26, 2021
Development of [<sup>18</sup>F]MIPS15692, a radiotracer with in vitro proof-of-concept for the imaging of MER tyrosine kinase (MERTK) in neuroinflammatory diseaseSiu Wai Wong, Lucy Vivash, Ramesh Mudududdla, et al.
Journal of Medicinal Chemistry|November 7, 2009
Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9aFeng Liu, Xin Chen, Abdellah Allali-Hassani, et al.
ACS Medicinal Chemistry Letters|June 5, 2012
Discovery of Novel Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic LeukemiaJing Liu, Chao Yang, Catherine Simpson, et al.
Nature Chemical Biology|February 16, 2023
Structural basis of paralog-specific KDM2A/B nucleosome recognitionCathy J Spangler, Aleksandra Skrajna, Caroline A Foley, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
SLAS Discovery : Advancing Life Sciences R & D|October 22, 2022
Discovery of hit compounds for methyl-lysine reader proteins from a target class DNA-encoded libraryDevan J Shell, Justin M Rectenwald, Peter H Buttery, et al.
Journal of Medicinal Chemistry|November 8, 2013
Pseudo-cyclization through intramolecular hydrogen bond enables discovery of pyridine substituted pyrimidines as new Mer kinase inhibitorsWeihe Zhang, Dehui Zhang, Michael A Stashko, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacyJohn A Allen, Julianne M Yost, Vincent Setola, et al.
Biochemistry|November 29, 2018
Correction to "Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID subunit 1"Junghyun L Suh, Brian Watts, Jacob I Stuckey, et al.
Biochemistry|March 21, 2018
Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1Junghyun L Suh, Brian Watts, Jacob I Stuckey, et al.
Science Signaling|July 18, 2019
Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancerDevon R Blake, Angelina V Vaseva, Richard G Hodge, et al.
European Journal of Medicinal Chemistry|September 26, 2021
Development of [<sup>18</sup>F]MIPS15692, a radiotracer with in vitro proof-of-concept for the imaging of MER tyrosine kinase (MERTK) in neuroinflammatory diseaseSiu Wai Wong, Lucy Vivash, Ramesh Mudududdla, et al.
Journal of Medicinal Chemistry|November 7, 2009
Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9aFeng Liu, Xin Chen, Abdellah Allali-Hassani, et al.
ACS Medicinal Chemistry Letters|June 5, 2012
Discovery of Novel Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic LeukemiaJing Liu, Chao Yang, Catherine Simpson, et al.
Nature Chemical Biology|February 16, 2023
Structural basis of paralog-specific KDM2A/B nucleosome recognitionCathy J Spangler, Aleksandra Skrajna, Caroline A Foley, et al.
Pageof 13